<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00804284</url>
  </required_header>
  <id_info>
    <org_study_id>M5A11</org_study_id>
    <nct_id>NCT00804284</nct_id>
  </id_info>
  <brief_title>Database Surveillance Safety Study of PENTACEL® Vaccine</brief_title>
  <official_title>Post-Licensure Safety Surveillance Study of Routine Use of PENTACEL® Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sanofi Pasteur, a Sanofi Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sanofi</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective for this study is to characterize the safety profile of PENTACEL® vaccine for
      identification of potential vaccine-related adverse events not currently associated with
      PENTACEL® vaccine administration.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be conducted at Kaiser Permanente Northern California and will commence with
      first use of licensed PENTACEL® vaccine within that organization.

      Vaccination databases will be reviewed to identify Diphtheria and tetanus toxoid with
      acellular pertussis (DTaP) vaccinations of accrued subjects. Medical encounter, emergency
      room, hospitalization, laboratory, state death reporting, and related databases will be
      reviewed to identify medical care events.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>A summary of all non-elective hospitalization and emergency room visits as well as outcome of interest from chart review.</measure>
    <time_frame>Up to 6 months post -dose 4 DTap Vaccination</time_frame>
    <description>Outcome of interest identified from Kaiser Permanente Medical Care Program (KPMCP) computerized records via International Classification of Diseases, 9th edition (ICD-9) codes, defined as:
Death,
Outpatient clinic visit for:
seizure occurring within 72 hours of vaccination, Guillain-Barré Syndrome, encephalopathy, encephalitis, alteration of consciousness (other than secondary to another diagnosis), or meningitis
hypersensitivity reactions (e.g. urticaria, angioedema, or anaphylaxis) occurring within 72 hours of vaccination,
new-onset autoimmune disease (including idiopathic thrombocytopenic purpura, hemolytic anemia).</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">62538</enrollment>
  <condition>Diphtheria</condition>
  <condition>Tetanus</condition>
  <condition>Pertussis</condition>
  <condition>Haemophilus Influenzae</condition>
  <arm_group>
    <arm_group_label>Pentacel Group</arm_group_label>
    <description>Infants initiated on PENTACEL® vaccine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Other DTap vaccines Group</arm_group_label>
    <description>Infants initiated on other DTaP vaccines</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>DTaP-IPV/Hib</intervention_name>
    <description>0.5 mL, Intramuscular</description>
    <arm_group_label>Pentacel Group</arm_group_label>
    <other_name>PENTACEL®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Other DTap Vaccines</intervention_name>
    <description>0.5 mL, Intramuscular</description>
    <arm_group_label>Other DTap vaccines Group</arm_group_label>
    <other_name>DAPTACEL®</other_name>
    <other_name>INFANRIX®</other_name>
    <other_name>PEDIARIX®</other_name>
    <other_name>TRIPEDIA®</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Receipt of DTaP vaccine during the study period by a previously unvaccinated subjects
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Receipt of DTaP vaccine during the study period by a previously unvaccinated child

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>6 Weeks</minimum_age>
    <maximum_age>24 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Director</last_name>
    <role>Study Director</role>
    <affiliation>Sanofi Pasteur Inc</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.sanofipasteur.com</url>
  </link>
  <link>
    <url>http://sanofi.com</url>
  </link>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 5, 2008</study_first_submitted>
  <study_first_submitted_qc>December 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2008</study_first_posted>
  <last_update_submitted>August 17, 2015</last_update_submitted>
  <last_update_submitted_qc>August 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>DAPTACEL®</keyword>
  <keyword>PENTACEL®</keyword>
  <keyword>Diphtheria</keyword>
  <keyword>Tetanus</keyword>
  <keyword>Pertussis</keyword>
  <keyword>Haemophilus influenzae type b</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Whooping Cough</mesh_term>
    <mesh_term>Tetanus</mesh_term>
    <mesh_term>Tetany</mesh_term>
    <mesh_term>Diphtheria</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

